HIGH DISEASE CONTROL AND STATE OF REMISSION WITH RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS DURING THE 6-YEAR LIMMITLESS STUDY
ACTA DERMATO-VENEREOLOGICA(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ACTA DERMATO-VENEREOLOGICA(2024)